Natixis Investment Managers International Buys 60 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Natixis Investment Managers International lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 0.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,840 shares of the medical equipment provider’s stock after purchasing an additional 60 shares during the period. Natixis Investment Managers International’s holdings in Intuitive Surgical were worth $3,994,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in ISRG. Baystate Wealth Management LLC raised its stake in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares during the period. MCF Advisors LLC raised its stake in Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after acquiring an additional 40 shares during the period. Headinvest LLC bought a new stake in Intuitive Surgical in the 3rd quarter valued at about $28,000. Stone House Investment Management LLC raised its stake in Intuitive Surgical by 100.0% in the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 50 shares during the period. Finally, Truvestments Capital LLC lifted its position in Intuitive Surgical by 137.2% in the third quarter. Truvestments Capital LLC now owns 102 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 59 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $411.00, for a total transaction of $575,400.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $411.00, for a total value of $575,400.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,385,753.30. The disclosure for this sale can be found here. Insiders sold 21,687 shares of company stock worth $8,367,952 in the last quarter. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Down 0.1 %

ISRG traded down $0.54 on Friday, hitting $417.61. 1,199,562 shares of the company’s stock traded hands, compared to its average volume of 1,153,523. The firm has a market cap of $148.13 billion, a price-to-earnings ratio of 75.38, a P/E/G ratio of 5.40 and a beta of 1.39. The company’s 50 day simple moving average is $388.98 and its 200-day simple moving average is $370.67. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $420.57.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.10. The business had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.00 EPS. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Stifel Nicolaus upped their target price on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Citigroup increased their target price on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. StockNews.com cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Robert W. Baird lowered their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a report on Friday, April 19th. Finally, Piper Sandler increased their target price on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a report on Friday, April 19th. Five research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $403.67.

Read Our Latest Report on Intuitive Surgical

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.